Telegram VKontakte Yandex Youtube

Latest news

News

FT: MSD nears $6bn biotech deal

US pharmaceutical giant MSD is in the final stages of negotiations to acquire biotech firm Terns Pharmaceuticals, the Financial Times reported, citing sources. The...
News

A plant for manufacturing heart valve bioprostheses has been launched in Kuzbass

NeoKor has commissioned a production facility in Kemerovo specialising in heart valve bioprostheses and other medical devices for cardiovascular surgery. Total investment in the...
News

Gilead Sciences buys Ouro Medicines in deal worth up to $2.18 billion

US biotech company Gilead Sciences said it would acquire Ouro Medicines, a privately held firm specialising in the development of antibody drugs for autoimmune...
News

Russian recombinant TB vaccine demonstrates favourable safety profile in clinical studies

The tuberculosis vaccine under development in Russia has demonstrated good tolerability during phase III clinical trials, Vladimir Gushchin, Deputy Director for Scientific Research at...
News

Russian researchers develop sea cucumber–based implant for post‑chemotherapy rehabilitation

Researchers from the Zelinsky Institute of Organic Chemistry (RAS), the Blokhin National Medical Research Centre of Oncology, the Baikov Institute of Metallurgy and Materials...
News

Russian State Corporation Rostech registers next-generation anaesthesia–respiratory apparatus Anestek

The Radioelectronic Technologies Concern (part of Rostech) has registered the domestically produced next-generation anaesthesia–respiratory apparatus Anestek for use in children weighing from 5 kg...
News

Antidiabetic and anti-obesity medications linked to lower depression risk in affected patients

Use of glucagon-like peptide-1 (GLP-1) receptor agonists, specifically semaglutide and liraglutide, is associated with a reduced risk of worsening symptoms of depression and anxiety...
News

AstraZeneca launches clinical trial for new dyslipidemia therapy in Russia

International biopharmaceutical company AstraZeneca has announced the launch of a local Phase II clinical trial (CT) in Russia, named LAZURE. The study will evaluate...

Most popular

«GxP News» — зарегистрированный товарный знак. Использование названия на латинице осуществляется на основании свидетельства Роспатента № 920870 от 03.02.2023 г. в соответствии с п. 3 ст. 3 Федерального закона от 01.06.2005 № 53-ФЗ «О государственном языке Российской Федерации». Все права защищены. © 2019–2026 ООО «Медиа-Фарм Новости».

Воспроизведение материалов допускается только при соблюдении ограничений, установленных правообладателем, при указании автора используемых материалов и ссылки на портал GxP News как на источник заимствования.

18+

WordPress Ads